Results 21 to 30 of about 119,198,728 (316)

Immunity to Vaccine-Preventable Infections in Healthcare Professionals Working in Infectious Diseases Hospitals

open access: yesЭпидемиология и вакцинопрофилактика, 2022
Relevance. During the ongoing pandemic of a new coronavirus infection (COVID-19), assessment of humoral immunity to vaccine preventable diseases in healthcare workers is crucial to estimate the risk of healthcare-associated infections. Aim. To assess the
O. V. Samodova   +2 more
doaj   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Hepatitis A surveillance in England--how many cases are not reported and does it really matter? [PDF]

open access: yes, 2006
Underreporting of hepatitis A infection in England may be high and a number of outbreaks have occurred undetected by routine surveillance. We evaluated surveillance of hepatitis A cases by employing capture-recapture analysis on data from two distinct ...
Grant, A   +3 more
core   +1 more source

Hepatitis A outbreak among men who have sex with men, Shinjuku, Japan, 2018

open access: yesWestern Pacific Surveillance and Response
Objective: In 2018, the Shinjuku City Department of Health detected excess cases of hepatitis A virus (HAV) infection. The objectives of this investigation were to characterize the outbreak, identify transmission routes among inpatient cases and make ...
Mariya Itaki   +8 more
doaj   +1 more source

Massive hepatitis A outbreak in Sri Lanka in 2009: an indication of increasing susceptibility and epidemiological shift?

open access: yesSri Lankan Journal of Infectious Diseases, 2013
Sri Lanka experienced an unprecedented outbreak of hepatitis A in 2009. We extracted data from different sources to get a proper estimate of actual disease incidence during that period.
NJ Dahanayaka, T Kiyohara, SB Agampodi
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Immunological and epidemiological effectiveness of pediatric vaccination against hepatitis A using a single dose of inactivated vaccine

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии
Hepatitis A is an acute liver disease caused by the hepatitis A virus (HAV), which can be prevented by means of vaccination. The standard hepatitis A vaccination schedule consists of two doses of inactivated vaccine, but for economic reasons and the ...
Mariya A. Lopatukhina   +2 more
doaj   +1 more source

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Investigation of Anti-HCV, Anti-HIV, and Anti-HAV IgG Seroprevalence in HBsAg-positive Patients

open access: yesViral Hepatitis Journal
Objectives: The objective of this study was to evaluate serologic markers anti-hepatitis C virus (anti-HCV), anti-hepatitis A virus immunoglobulin G (anti-HAV IgG), anti-human immunodeficiency virus antibody (anti-HIV)] associated with HCV, HAV, and HIV ...
Yeşim Çağlar, Enes Dalmanoğlu
doaj   +1 more source

Hepatitis A, Italy [PDF]

open access: yesEmerging Infectious Diseases, 2005
To the Editor: Hepatitis A virus (HAV) infection rates are very low in industrialized countries. A noticeable fall in the prevalence of HAV antibodies (anti-HAV) has been reported in southern European and Mediterranean countries such as Spain (1) and Greece (2), reflecting improvements in hygiene standards in the last decades.
D'AMELIO, Raffaele   +7 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy